Effect of chronic prostatitis on angiogenic activity and serum prostate specific antigen level in benign prostatic hyperplasia

Kaohsiung Journal of Medical Sciences

Volumn 23, Issue 8, 2007, Pages 387-394

  Koseoglu, Resit Dogan ^a   Erdemir, Fikret ^a   Parlaktas, Bekir Suha ^a   Filiz, Nurper Onuk ^a   Uluocak, Nihat ^a   Etikan, Ilker ^a  

^a GAZIOSMANPASA UNIVERSITY   (Turkey)

Author keywords

Angiogenesis; Benign prostatic hyperplasia; Chronic prostatitis; Microvessel density; Prostate specific antigen

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANGIOGENESIS; ANTIGEN EXPRESSION; ARTICLE; BIOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; GLEASON SCORE; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATION; PROSTATE ADENOCARCINOMA; PROSTATE HYPERTROPHY; PROSTATITIS; TRANSURETHRAL RESECTION;

EID: 34548410052     PISSN: 1607551X     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0257-5655(07)70002-0     Document Type: Article

References (25)

1. Foley SJ, Bailey DM. Microvessel density in prostatic hyperplasia. BJU Int 2000;85:70-3.
2. Weingartner K, Ben-Sasson SA, Stewart R, et al. Endothelial cell proliferation activity in benign prostatic hyperplasia and prostate cancer: an in vitro model for assessment. J Urol 1998;159:465-70.
3. Shih SJ, Dall'Era MA, Westphal JR, et al. Elements regulating angiogenesis and correlative microvessel density in benign hyperplastic and malignant prostate tissue. Prostate Cancer Prostatic Dis 2003;6:131-7.
4. Coussens LM, Werb Z. Inflammatory cells and cancer: think different! J Exp Med 2001;193:23-6.
5. Stamey TA, Yang N, Hay AR, et al. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 1987;317:909-16.
6. Bahnson RR. Elevation of prostate-specific antigen from bacillus Calmette-Guerin induced granulomatous prostatitis. J Urol 1991;146:1368-9.
7. Neal DE, Clejan S, Sarma D, et al. Prostate specific antigen and prostatitis. I. Effect of prostatitis on serum PSA in the human and non-human primate. Prostate 1992;20:105-11.
8. Yuan JJ, Coplen DE, Petros JA, et al. Effects of rectal examination, prostatic massage, ultrasonography and needle biopsy on serum prostate specific antigen levels. J Urol 1992;147:810-4.
9. Cetinkaya M, Gunce S, Ulusoy E, et al. Relationship between prostate specific antigen density, microvessel density and prostatic volume in benign prostatic hyperplasia and advanced prostatic carcinoma. Int Urol Nephrol 1998;30:581-5.
10. Papadopoulos I, Sivridis E, Giatromanolaki A, et al. Tumor angiogenesis is associated with MUC1 overexpression and loss of prostate-specific antigen expression in prostate cancer. Clin Cancer Res 2001;7:1533-8.
11. Campbell SC. Advances in angiogenesis research: relevance to urological oncology. J Urol 1997;158:1663-74.
12. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996;86:853-4.
13. Bouck N, Stellmach V, Hsu SC. How tumors become angiogenic. Adv Cancer Res 1996;68:135-74.
14. Polverini PJ. The pathophysiology of angiogenesis. Crit Rev Oral Biol Med 1995;6:230-47.
15. Brawer MK, Deering RE, Brown M, et al. Predictors of pathologic stage in prostatic carcinoma. The role of neovascularity. Cancer 1994;73:678-87.
16. Leibovich SJ, Polverini PJ, Shepard HM, et al. Macrophage induced angiogenesis is mediated by tumour necrosis factor-a. Nature 1987;329:630-2.
17. Bigler SA, Deerig RE, Brawer MK. Comparison of microscopic vascularity in benign and malignant prostate tissue. Hum Pathol 1993;24:220-6.
18. Deering RE, Bigler SA, Brown M, et al. Microvascularity in benign prostatic hyperplasia. Prostate 1995;26:111-5.
19. Heidtmann HH, Nettelbeck DM, Mingels A, et al. Generation of angiostatin-like fragments from plasminogen by prostate-specific antigen. Br J Cancer 1999;81:1269-73.
20. Varma M, Morgan M, Jasani MB, et al. Polyclonal anti-PSA is more sensitive but less specific than monoclonal anti-PSA: implications for diagnostic prostatic pathology. Am J Clin Pathol 2002;118:202-7.
21. Goldstein NS. Immunophenotypic characterization of 225 prostate adenocarcinomas with intermediate or high Gleason scores. Am J Clin Pathol 2002;117:471-7.
22. Vartanian RK, Weidner N. Endothelial cell proliferation in prostatic carcinoma and prostatic hyperplasia: correlation with Gleason's score, microvessel density, and epithelial cell proliferation. Lab Invest 1995;73:844-50.
23. Strohmeyer D, Strauss F, Rossing C, et al. Expression of bFGF, VEGF and c-met and their correlation with microvessel density and progression in prostate carcinoma. Anticancer Res 2004;24:1797-804.
24. Sinha AA, Quast BJ, Reddy PK, et al. Microvessel density as a molecular marker for identifying high-grade prostatic intraepithelial neoplasia precursors to prostate cancer. Exp Mol Pathol 2004;77:153-9.
25. Stefanou D, Batistatou A, Kamina S, et al. Expression of vascular endothelial growth factor (VEGF) and association with microvessel density in benign prostatic hyperplasia and prostate cancer. In Vivo 2004;18:155-60.